@docwas

Professor of Diabetes at University Hospital Birmingham by trade, Indian by birth, British by work, Cricketer by choice and Human by Right.....

 Birmingham UK
birmingham-endocrineclinic.co
Joined August 2009
  • Tweets8.9K
  • Following710
  • Followers5.2K
860Media
Retatrutide Once Weekly for Treatment of Obstructive Sleep Apnea resulted in significant improvements of AHI scores nejm.org/doi/abs/10.1056/NEJ…

Retatrutide Once Weekly for Treatment of Obstructive Sleep Apnea | NEJM

Retatrutide, an investigational triple agonist of glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1, and glucagon receptors, may be useful for treating obstructive sleep apnea (...

nejm.org
2
4
360
GLP-1 receptor agonist initiation and risk of psychiatric hospitalisation and emergency department presentation in adults with schizophrenia and type 2 diabetes in the USA: an observational cohort study using electronic health records data thelancet.com/journals/lanps…

GLP-1 receptor agonist initiation and risk of psychiatric hospitalisation and emergency department...

GLP-1-based therapy initiation was associated with lower psychiatric acute-care use than non-initiation and initiation of DPP-4 or SGLT2 inhibitors in adults with schizophrenia and type 2 diabetes....

thelancet.com
2
4
375
Our paper on the effects of behavioural sleep intervention on Obesity @AbdTahrani @samiul_m @Feaz2011 @Nirantharakumar @UHBDiabetes onlinelibrary.wiley.com/doi/…

The Effect of Behavioral Sleep Interventions on Measures of Obesity, Dietary Intake and Physical...

Background As poor sleep negatively impacts on adiposity, there is interest in examining whether improving sleep can improve adiposity markers. We reviewed studies aimed at improving sleep using...

onlinelibrary.wiley.com
1
2
15
583
Safety of glucose lowering therapy in first trimester of pregnancy. GLP -1 slight increase risk CV defect link.springer.com/article/10…

Safety of glucagon-like peptide-1 receptor agonists and other new-generation glucose-lowering...

Diabetologia - Glucagon-like peptide-1 receptor agonists (GLP-1RA) and other second-line glucose-lowering agents are increasingly used among women of reproductive age. Data on the safety of these...

link.springer.com
2
4
529
SURPASS CVOT sub analysis for retinopathy with Tirzepatide. No worsening when compared to Dulaglutide @EASDnews #EASD2026
3
14
855
Traditional EASD curry night in Milan #EASD2026 @kamleshkhunti @AmarPut @AliRacaniere @kamleshkhunti @rahmoh1
2
1
22
897
This is verified account of Kamlesh @kamleshkhunti please follow @AliRacaniere @m_alikaramat @AliaGilani @SouthAsianHF @rahmoh1 @ShivaniM_KC @AskDrShashank @banshisaboo @dramitaol @AmarPut @SouthAsianHF @purvi_chawla @sribellary spread the word @Azeem_Majeed @ClareHambling
Professor Kamlesh Khunti
@kamleshkhuntiSep 27
Dear Friends Unfortunately I didn't get my hacked twitter account back & have started a new account. Please do follow me again🙏🏻 @parthaskar @ShivaniM_KC @mmamas1973 @WilmotEmma @EASDnews @ADA_DiabetesPro @DiabetologiaJnl @LDC_tweets @drpratikc @AmarPut @DanielJDrucker
2
6
701
Prof. Wasim Hanif OBE retweeted
Professor Kamlesh Khunti
@kamleshkhuntiSep 27
Dear Friends Unfortunately I didn't get my hacked twitter account back & have started a new account. Please do follow me again🙏🏻 @parthaskar @ShivaniM_KC @mmamas1973 @WilmotEmma @EASDnews @ADA_DiabetesPro @DiabetologiaJnl @LDC_tweets @drpratikc @AmarPut @DanielJDrucker
2
9
1
11
1,284
HCP factors influence delivery of Obesity care @EASDnews #EASD2026
1
6
345
Addressing psychological barriers for obesity management. The 5 As…@EASDnews #EASD2026
1
5
347
SURMOUNT-MAINTAIN answers the important question of “What happens when you stop a Mounjaro?” Which every patient wants to know….if you stop completely you will gain weight @EASDnews #EASD2026
2
1
1
19
2,093
The challenges managing obesity in South Asian populations and strategies to mitigate risk of Sarcopenia @EASDnews #EASD2026 DASG symposium
1
15
460
Prof. Wasim Hanif OBE retweeted
SAHF.ORG.UK@SouthAsianHFSep 25
📢 SAHF Poster Competition: Deadline 2 October! There’s still time to submit your poster for the SAHF Poster Competition. Showcase your work at the SAHF Annual Conference and share your research with colleagues and delegates. Submit by 2 October 2026.
1
4
5
195
Novo CagriSema shows superior weight loss to Tirzepatide novonordisk.com/news-and-med…

News Details

News Details

novonordisk.com
1
199
Great message from @AlexZverev on winning US open. Giving hope to millions of people with type 1 diabetes in countries without access to latest treatments @DiabetesUK @BT1DUK @IntDiabetesFed @Jazzsethi95 instagram.com/reel/DdP456yCB…

Australian Open (@australianopen) • Instagram reel

instagram.com
2
4
271
SURMONT 1 DXA study with Tirzepatide , 75% weight loss is fat mass and 25% lean mass which is comparable to placebo dom-pubs.onlinelibrary.wiley…

Body composition changes during weight reduction with tirzepatide in the SURMOUNT‐1 study of adults...

Aims We assessed changes in body composition following tirzepatide treatment in a substudy of participants with obesity or overweight from the SURMOUNT-1 trial, overall and post hoc in clinically...

dom-pubs.onlinelibrary.wiley.com
5
5
475
Cultural competence in the NHS bmj.com/content/394/bmj-2026…

Faith and the NHS: How a lack of cultural literacy is failing patients and staff

Better faith and cultural literacy in the NHS could improve health outcomes and staff wellbeing, according to a new report “To meet the needs of modern Britain, the NHS must understand the people it...

bmj.com
1
225
GLP-1 receptor agonists at the crossroads of metabolic and gut inflammation: Implications for people with type 2 diabetes and inflammatory bowel disease journals.sagepub.com/doi/10.…

GLP-1 receptor agonists at the crossroads of metabolic and gut inflammation: Implications for...

Obesity and type 2 diabetes now coexist with IBD. Beyond glucose and weight effects, GLP-1 receptor agonists reduce MACE and lower systemic inflammatory biomark...

journals.sagepub.com
207
Prof. Wasim Hanif OBE retweeted
SAHF.ORG.UK@SouthAsianHFSep 3
📢 FREE registration is OPEN! Join us 26–27 Nov for the 27th SAHF Annual Conference at NCC Birmingham. Connect with colleagues & hear from experts in multimorbidity, diabetes, cardiovascular & obesity care. Secure your free place 👇 sahf.typeform.com/conf26
4
7
241
Prof. Wasim Hanif OBE retweeted
SAHF.ORG.UK@SouthAsianHFSep 3
The deadline to enter the 2026 SAHF Poster Competition is fast approaching! Don't miss your opportunity to showcase your work at our 27th Annual Conference this November. Find out more at: sahf.org.uk/events
3
3
226
Load more